Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (19317)	3/10/1999 6:01:00 PM
From: moby_dick	Respond to of 122087

Go here for explanation of the different Merck companies ===> merck-ltd.co.uk

To: Anthony@Pacific who wrote (19317)	3/10/1999 6:10:00 PM
From: Cube	Read Replies (1) \| Respond to of 122087

IMCL, I'm not even very skeptical Anthony. You can't get to phase 3 from 2 on any trumped up or BS results. FDA knows the difference between rodentcide and complete elimination of tumor in 88% of human subjects. FDA looked at the results and immediately granted them a phase 3 application. CNBC also talked about a "possibility" of something called sympathetic progress(I think that was the term) which means if results in phase 3 continue with this high of a percentage, they'll approve it for use in terminal patients before phase 3 is even concluded. I know anything can happen, but I really like this one. Cube